Koers Lotus Pharmaceutical Co., Ltd. Taipei Exchange
Aandelen
1795
TW0001795003
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
108 TWD | +0,47% | -4,42% | -.--% |
Omzet 2024 * | 18,86 mld. 585 mln. 538 mln. | Omzet 2025 * | 20,95 mld. 650 mln. 598 mln. | Marktkapitalisatie | 75,77 mld. 2,35 mld. 2,16 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 4,82 mld. 150 mln. 138 mln. | Nettowinst (verlies) 2025 * | 6,17 mld. 191 mln. 176 mln. | EV/omzet 2024 * | 4,38 x |
Nettoschuld 2024 * | 6,89 mld. 213 mln. 196 mln. | Nettoschuld 2025 * | 2,64 mld. 82,01 mln. 75,48 mln. | EV/omzet 2025 * | 3,74 x |
K/w-verhouding 2024 * |
15,4
x | K/w-verhouding 2025 * |
12,1
x | Werknemers | - |
Dividendrendement 2024 * |
1,87% | Dividendrendement 2025 * |
2,62% | Vrij verhandelbaar | 48,47% |
Recentste transcriptie over Lotus Pharmaceutical Co., Ltd.
1 dag | +0,47% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 29-09-14 | |
I ling Tian
DFI | Director of Finance/CFO | - | 01-11-16 |
Ying Ming Yue
COO | Chief Operating Officer | - | 01-12-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Vilhelm Wessman
CHM | Chairman | 54 | 23-04-15 |
Director/Board Member | 60 | 11-08-14 | |
Director/Board Member | 61 | 23-04-15 |
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,78% | 723 mld. | |
+32,82% | 598 mld. | |
-3,51% | 364 mld. | |
+19,94% | 331 mld. | |
+5,14% | 288 mld. | |
+16,64% | 244 mld. | |
-4,13% | 208 mld. | |
+10,63% | 210 mld. | |
+9,32% | 169 mld. |
- Beurs
- Aandelen
- Koers 1795
- Koers 1795